BioTransplant gains rights to purification device:
This article was originally published in Clinica
Executive Summary
Activated Cell Therapy has granted BioTransplant exclusive worldwide rights to use its bone marrow stem cell isolation and enrichment device to assist in organ transplants. The device will enhance BioTransplant's AlloMune and XenoMune systems to create tolerance to transplanted human and pig organs.